Page last updated: 2024-10-27

flumazenil and Bladder Cancer

flumazenil has been researched along with Bladder Cancer in 1 studies

Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Russo, R1
Ravagnan, R1
Veschi, G1
Dellino, E1
Aveni, MR1
Buzzetti, V1
Dormia, G1
Patelli, E1
Gonnella, G1
Iapichino, G1

Other Studies

1 other study available for flumazenil and Bladder Cancer

ArticleYear
[Sedation with flunitrazepam and its antagonism with flumazenil in endoscopic urological procedures: our clinical experience].
    Archivio italiano di urologia, nefrologia, andrologia : organo ufficiale dell'Associazione per la ricerca in urologia = Urological, nephrological, and andrological sciences, 1991, Volume: 63, Issue:3

    Topics: Adult; Aged; Blood Pressure; Conscious Sedation; Consciousness; Cystoscopy; Female; Flumazenil; Flun

1991